BackLumos Pharma Overview

Lumos Pharma Current Cash

Latest current cash for LUMO: $14M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$13.52M
↓ 61.98% YoYΔ $-22.04M vs prior year quarter

Peer trimmed avg / median

Loading

Lumos Pharma Current Cash History

Loading

Lumos Pharma vs. peers: Current Cash Comparison

Loading

Lumos Pharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lumos Pharma (LUMO) FAQ

Lumos Pharma (LUMO) currently reports a current cash of $14M as of September 2024. That compares with $36M in the prior-year period — down 62.0% year over year. Use the charts on this page to explore Lumos Pharma's current cash history and peer comparisons.

Lumos Pharma's current cash decreased from $36M to $14M — a 62.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lumos Pharma reported $14M in current cash as of September 2024. That compares with $36M in the prior-year period — down 62.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lumos Pharma, and consider following LUMO for alerts when major investors trade the stock.

Lumos Pharma is classified in the Healthcare sector. On current cash, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LUMO with unrelated industries.